nm 006666 Search Results


nm 006666  (OriGene)
90
OriGene nm 006666
Nm 006666, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nm 006666/product/OriGene
Average 90 stars, based on 1 article reviews
nm 006666 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ruvbl2  (OriGene)
94
OriGene ruvbl2
A. Top drawing: schematic representation of the N- and C-terminally extended LBE fragment. The numbers indicate the number of amino acids in each of the LBE segments. Below is a FLAG immunoblot of an IP of the 120aa LBE fragment after overnight binding to ETV7 in vitro . Control (CTRL) shows the binding of human <t>RUVBL2</t> to ETV7. B. Left panel, schematic representation of the different deletions of the N- and C-terminal extended LBE fragment (120 amino acids) and underneath the amino acid sequence of the LBE domain with the amino acids essential for ETV7 binding in red; Right, FLAG immunoblot of an ETV7 IP of the different LBE fragments after overnight binding to ETV7 in vitro . Lanes containing fragments that lost binding to ETV7 are boxed in red. C. FRB and LBE bind to ETV7 simultaneously. FLAG immunoblot of an ETV7 IP of LBE (120 amino acids) and Ndel-FRB fragments (ETV7: LBE: Ndel-FRB = 1:1:1, 1:1:5, 1:5:1) after overnight binding to ETV7 in vitro . D. Binding of Nde-FRB to ETV7 fragments containing the PNT domain and binding of LBE (120 amino acids) to ETV7 fragments containing the PNT and ETS domains in vitro .
Ruvbl2, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ruvbl2/product/OriGene
Average 94 stars, based on 1 article reviews
ruvbl2 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


A. Top drawing: schematic representation of the N- and C-terminally extended LBE fragment. The numbers indicate the number of amino acids in each of the LBE segments. Below is a FLAG immunoblot of an IP of the 120aa LBE fragment after overnight binding to ETV7 in vitro . Control (CTRL) shows the binding of human RUVBL2 to ETV7. B. Left panel, schematic representation of the different deletions of the N- and C-terminal extended LBE fragment (120 amino acids) and underneath the amino acid sequence of the LBE domain with the amino acids essential for ETV7 binding in red; Right, FLAG immunoblot of an ETV7 IP of the different LBE fragments after overnight binding to ETV7 in vitro . Lanes containing fragments that lost binding to ETV7 are boxed in red. C. FRB and LBE bind to ETV7 simultaneously. FLAG immunoblot of an ETV7 IP of LBE (120 amino acids) and Ndel-FRB fragments (ETV7: LBE: Ndel-FRB = 1:1:1, 1:1:5, 1:5:1) after overnight binding to ETV7 in vitro . D. Binding of Nde-FRB to ETV7 fragments containing the PNT domain and binding of LBE (120 amino acids) to ETV7 fragments containing the PNT and ETS domains in vitro .

Journal: bioRxiv

Article Title: Assembly of mTORC3 involves binding of ETV7 to two separate sequences in the mTOR kinase domain

doi: 10.1101/2024.03.19.583970

Figure Lengend Snippet: A. Top drawing: schematic representation of the N- and C-terminally extended LBE fragment. The numbers indicate the number of amino acids in each of the LBE segments. Below is a FLAG immunoblot of an IP of the 120aa LBE fragment after overnight binding to ETV7 in vitro . Control (CTRL) shows the binding of human RUVBL2 to ETV7. B. Left panel, schematic representation of the different deletions of the N- and C-terminal extended LBE fragment (120 amino acids) and underneath the amino acid sequence of the LBE domain with the amino acids essential for ETV7 binding in red; Right, FLAG immunoblot of an ETV7 IP of the different LBE fragments after overnight binding to ETV7 in vitro . Lanes containing fragments that lost binding to ETV7 are boxed in red. C. FRB and LBE bind to ETV7 simultaneously. FLAG immunoblot of an ETV7 IP of LBE (120 amino acids) and Ndel-FRB fragments (ETV7: LBE: Ndel-FRB = 1:1:1, 1:1:5, 1:5:1) after overnight binding to ETV7 in vitro . D. Binding of Nde-FRB to ETV7 fragments containing the PNT domain and binding of LBE (120 amino acids) to ETV7 fragments containing the PNT and ETS domains in vitro .

Article Snippet: ETV7 protein (Cat # TP307742) and RUVBL2 (Cat # TP300933) were purchased from Origene.

Techniques: Western Blot, Binding Assay, In Vitro, Control, Sequencing